Jonathan Davis
30Patents
8h-index
26Co-inventors
71Inventor score
Filing activity: Dec 29, 2006 → May 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8420098B2 | Fibronectin based scaffold domain proteins that bind to PCSK9 | Chemistry; Metallurgy | 77 | Active |
| US8871912B2 | Engineered heterodimeric protein domains | Chemistry; Metallurgy | 53 | Active |
| US9505848B2 | Engineered heterodimeric protein domains | Chemistry; Metallurgy | 37 | Active |
| US9522951B2 | Fibronectin binding domains with reduced immunogenicity | Chemistry; Metallurgy | 17 | Active |
| US9416170B2 | Fibronectin binding domains with reduced immunogenicity | Chemistry; Metallurgy | 14 | Active |
| US9469676B2 | Fc fusion proteins comprising novel linkers or arrangements | Physics | 13 | Active |
| US9765132B2 | Fibronectin binding domains with reduced immunogenicity | Chemistry; Metallurgy | 8 | Active |
| US8691952B2 | Anti-CD19 antibodies with reduced immunogenicity | Chemistry; Metallurgy | 8 | Active |
| US9856309B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 7 | Active |
| US10787494B2 | Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use | Emerging Cross-Sectional Technologies | 6 | Active |
| US9234027B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 6 | Active |
| US10604556B2 | Fibronectin binding domains with reduced immunogenicity | Chemistry; Metallurgy | 4 | Active |
| US11359000B2 | Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use | Emerging Cross-Sectional Technologies | 3 | Active |
| US8957195B2 | Anti-CD19 antibodies with reduced immunogenicity | Chemistry; Metallurgy | 3 | Active |
| US10442851B2 | Serum albumin-binding fibronectin type III domains | Chemistry; Metallurgy | 3 | Active |
| US10947297B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 3 | Active |
| US10464995B2 | Fibronectin binding domains with reduced immunogenicity | Chemistry; Metallurgy | 2 | Active |
| US10214579B2 | Fc fusion proteins comprising novel linkers or arrangements | Physics | 1 | Active |
| US10072092B2 | Methods of use of anti-CD19 antibodies with reduced immunogenicity | Chemistry; Metallurgy | 1 | Active |
| US11858979B2 | Fibronectin based scaffold domain proteins that bind PCSK9 | Chemistry; Metallurgy | 0 | Active |
| US11203630B2 | Serum albumin-binding fibronectin type III domains | Chemistry; Metallurgy | 0 | Active |
| US10407490B2 | Polypeptides targeting HIV fusion | Chemistry; Metallurgy | 0 | Active |
| US11155602B2 | Polypeptides targeting HIV fusion | Chemistry; Metallurgy | 0 | Active |
| US11447538B2 | Fibronectin based scaffold proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US11535868B2 | Miniaturized dystrophins having spectrin fusion domains and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.